Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma

Clinical trial NCT00777153 · COMPLETED

Trial details

NCT number: NCT00777153
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2008-10-01
Primary completion: 2010-04-01
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.